KIDNEY TRANSPLANT

This study looks at how well the HPV9 vaccine (Gardasil 9) works in people who have had a kidney transplant. About 30 adults aged 18 to 45 who are at least 6 months post-transplant will receive the vaccine. Researchers will measure their antibody levels over 2 years and compare t…

This early-phase study tests whether a single infusion of special immune cells (regulatory dendritic cells) from a living kidney donor can help prevent organ rejection in the recipient. The cells are given one week before the transplant, and 28 people (14 donors and 14 recipients…

This study looks at whether giving testosterone to men with low testosterone and end-stage kidney disease before a kidney transplant can help them recover better and more safely. About 50 men will receive testosterone therapy for at least 3 months before their transplant, and the…

This study looks at whether a supervised physical fitness program can help people with a high body mass index (40-44) lose weight so they can become active on the kidney transplant waiting list. Ten adults who are currently listed as inactive due to obesity will take part. The ma…

This study looks at whether dapagliflozin, a drug used for diabetes, can help protect kidney function in people who received a kidney from a living donor. About 54 adult patients will take the drug daily for a year, starting one month after transplant. Researchers will measure ki…

This study checks kidney transplant patients for inherited gene changes that raise cancer risk. Because transplant patients take drugs that weaken the immune system, they face a higher chance of cancer. By finding these genes early, doctors hope to improve cancer screening and ca…

This study looks at how donated kidneys are used around the world. Researchers will study data from 300,000 kidney donations to find patterns and differences between countries. The goal is to learn why some kidneys are thrown away and how to use them better so more people can get…